Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases
US employers are moving to eliminate coverage for GLP-1 weight-loss medications by 2027 amid rising utilization rates.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Multiple employers across the United States are preparing to remove coverage for GLP-1 obesity drugs starting in 2027. This shift comes as organizations reevaluate pharmacy benefit models in response to increased drug usage.
Coverage from Reuters, The Wall Street Journal, and Yahoo Finance highlights a broader trend of corporate entities rethinking pharmaceutical benefit structures. Modern Healthcare and Fierce Healthcare note that the discussion extends to the unbundling of pharmacy benefit manager models, with CalMatters specifically highlighting the fiscal pressure placed on California's public employee health plans.
Future developments remain dependent on how individual employers adjust their insurance plans for the upcoming year. Coverage does not yet specify which organizations will enact these changes or the potential impact on specific regional health systems.
Synthesized by PULSE from the headlines below under a strict no-invention contract. Updated 27m ago.
Quick answers
When will some employers begin dropping coverage?
The planned changes are set to take effect in 2027.
What is driving this change in employer benefits?
Coverage indicates that increased use of GLP-1 obesity drugs is a primary factor leading employers to rethink their pharmacy benefits.
Are there discussions regarding public employee coverage?
Yes, reports indicate that questions regarding the affordability of covering these drugs for public employees are being raised, specifically in California.
Coverage (6)
- Your Weight-Loss Drugs Are Next on the Corporate Chopping Block WSJ · 6h ago
- Can California afford to cover Ozempic for public employees? CalMatters · 6h ago
- U.S. employers dropping GLP-1 weight loss drug coverage in 2027 Yahoo Finance · 6h ago
- Employers are rethinking pharmacy benefits: 5 things to know Modern Healthcare · 6h ago
- PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models Fierce Healthcare · 6h ago
- Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases Reuters · 6h ago
Topics
Related trends
GLP-1 Users Get Surgery for 'Ozempic Ears' Side Effect
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.